4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(2,2-dimethyl-1-oxopropoxy)methyl ester, hydrochloride (1:1), (2S,5R,6R)- cas no:32887-03-9
Synonyms: 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, (2S,5R,6R)- (9CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, [2S-(2a,5a,6b)]-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,hydroxymethyl ester pivalate (ester), monohydrochloride, (+)- (8CI); Melysin;Pivmecillinam hydrochloride; Selexid
Name4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(2,2-dimethyl-1-oxopropoxy)methyl ester, hydrochloride (1:1), (2S,5R,6R)-
CAS32887-03-9
Synonyms4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, (2S,5R,6R)- (9CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, [2S-(2a,5a,6b)]-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,hydroxymethyl ester pivalate (ester), monohydrochloride, (+)- (8CI); Melysin;Pivmecillinam hydrochloride; Selexid
EINECS(EC#)251-278-7
Molecular FormulaC21H33 N3 O5 S . Cl H
Molecular Weight476.09
Safety
Moderately toxic by ingestion, subcutaneous, and intravenous routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of SOx, NOx, and HCl.
1. |
|
orl-mky TDLo:57,330 mg/kg (91D male):REP
|
|
JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 2 (1976),171. |
2. |
|
orl-rat LD50:9500 mg/kg
|
|
NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),632. |
3. |
|
scu-rat LD50:2100 mg/kg
|
|
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 9 (1978),1066. |
4. |
|
ivn-rat LD50:465 mg/kg
|
|
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 9 (1978),1066. |
5. |
|
orl-mus LD50:3020 mg/kg
|
|
NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),632. |
6. |
|
scu-mus LD50:1930 mg/kg
|
|
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 9 (1978),1066. |
7. |
|
ivn-mus LD50:475 g/kg
|
|
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 9 (1978),1066. |